Hello, Fool! | Login | Signup | My Fool
Oct 6, 2008 10:24 AM ET | Feedback | Site Changes | Help
The Company is a research-based pharmaceutical company focused on discovering, developing and commercializing differentiated products that address unmet medical needs, and are prescribed principally by primary care physicians.
View Ticker Page (SEPR)
Results 1 - 10 of 11 : 12
Recs
TMFBBQPorkMogul (29.74) Submitted: 6/28/06 3:42 PM : Start Price: $56.71 SEPR Score: -57.28
Possible acquisition by Pfizer
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
rontime2 (37.49) Submitted: 4/19/07 4:02 PM : Start Price: $50.34 SEPR Score: -39.83
Beaten down
al62lopez (47.69) Submitted: 1/24/07 6:56 PM : Start Price: $62.31 SEPR Score: -48.30
Lunesta the #1 Sleep aide on the maket a billion drug.
whitedevilap (< 20) Submitted: 3/02/07 4:56 PM : Start Price: $49.46 SEPR Score: -44.65
Strong pipeline. Depressed price. New leadership. Buyout candidate.
Stockman1212 (84.81) Submitted: 3/24/08 10:53 AM : Start Price: $19.31 SEPR Score: 5.50
Solid
esf123 (< 20) Submitted: 3/10/08 8:43 PM : Start Price: $18.72 SEPR Score: 5.54
Very close to a bottom ...
MattCraig (33.04) Submitted: 2/29/08 11:53 AM : Start Price: $22.14 SEPR Score: -5.55
risk/reward quite favorble relative to their new guidance
5highpockets (55.69) Submitted: 10/11/07 11:17 AM : Start Price: $27.38 SEPR Score: -8.44
Sepracor continues to prove that it has what it takes to make ii in pharmaceuticals. Lunesta is proof of that. Keep this one for a while!!
doodler95242 (75.71) Submitted: 8/01/07 9:40 PM : Start Price: $28.50 SEPR Score: -15.57
The market over-reacted to the recent earnings. The company is a good take-over target.
JPDemers (75.10) Submitted: 7/24/07 5:39 PM : Start Price: $38.55 SEPR Score: 28.05
Pipeline doesn't hold any blockbuster candidates, expenses are high, and their flagship products are not doing as well as hoped. Xopenex is under price pressure, and Lunesta is running up against generic versions of Ambien.
Terms & Conditions
RSS Headlines
Fool UK